Tamoxifen Citrate

CAS 54965-24-1 7 current records 8 historicalSmall Molecule

Who holds supplier records for Tamoxifen Citrate? 7 organisations hold a current record for Tamoxifen Citrate: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Germany (2), India (2), Italy (1), Netherlands (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tamoxifen Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tamoxifen-citrate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tamoxifen Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Tamoxifen Citrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Tamoxifen Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
BO-CHEM PRIVATE LIMITED MumbaiIN
CEP 2024-595 - Rev 00
Tamoxifen citrate
Oct 2026—
TAPI NL B.V. AmsterdamNL
CEP 1999-180 - Rev 07
Tamoxifen citrate
Jul 2025—
EXCELLA GMBH & CO. KG FeuchtDE
CEP 2021-495 - Rev 03
Tamoxifen citrate, Milled A; Milled Z
Mar 2025Inspected Apr 2026
Germany
CHEMISCHE FABRIK BERG GMBH Bitterfeld-WolfenDE
CEP 2022-463 - Rev 01
Tamoxifen citrate, Micronised, Non-micronised [10102/3]
Sept 2024Inspected May 2024
Germany
OLON S.P.A. RodanoIT
R2-CEP 1995-016 - Rev 05
Tamoxifen citrate
Aug 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Tamoxifen Citrate are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • China · Inactive DMF 27466 · filed Aug 2013
  • YANGTZE RIVER PHARMACY GROUP JIANGSU HAI CI BIOLOGICAL PHARMACY CO LTD
    Inactive DMF 19284 · filed Mar 2006
  • Hungary · Inactive DMF 15121, 5310 · filed Oct 2000
  • CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
    Inactive DMF 10681 · filed Dec 1993
  • LACHEMA BRNO
    Inactive DMF 9531 · filed Jan 1992
  • France · Inactive DMF 5612 · filed Dec 1984
  • Finland · Inactive DMF 5363 · filed Apr 1984
  • FUJISAWA DEUTSCHLAND GMBH
    Inactive DMF 5060 · filed Jun 1983

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Tamoxifen Citrate is a nonsteroidal antiestrogen that is used in the treatment of breast cancer. It acts as a selective estrogen receptor modulator that blocks estrogen effects in the breast tissue.

Chemical identity

IUPAC name
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
Canonical SMILES
CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChIKey
FQZYTYWMLGAPFJ-OQKDUQJOSA-N
Synonyms
Nolvadex API, i.c.i.46474 citrate, ici 46,474, ici-46474, kessar, nolvadex, nourytam, nsc-180973, nsc-757345, soltamox, tamofene, tamoxifeni citras

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Estrogen Agonist/Antagonist
Mechanism of action
Selective Estrogen Receptor Modulators

Therapeutic areas

OncologyEndocrinologyGynecology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tamoxifen Citrate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Tamoxifen Citrate: EXCELLA GMBH AND CO KG (Germany), OLON SPA (Italy), TAPI NL BV (Netherlands), APITORIA PHARMA PRIVATE LTD (India), YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (China), CHEMISCHE FABRIK BERG GMBH (Germany) and BO-CHEM PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tamoxifen Citrate Drug Master Files are active?

EXCELLA GMBH AND CO KG (DMF 5204), OLON SPA (DMF 21757, 6735), TAPI NL BV (DMF 5500), APITORIA PHARMA PRIVATE LTD (DMF 41084) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (DMF 34297). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tamoxifen Citrate records mean?

8 organisations have only inactive Type II DMFs for Tamoxifen Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tamoxifen Citrate have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Tamoxifen Citrate on the EDQM register, including BO-CHEM PRIVATE LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL), EXCELLA GMBH & CO. KG Feucht (DE), CHEMISCHE FABRIK BERG GMBH Bitterfeld-Wolfen (DE) and OLON S.P.A. Rodano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tamoxifen Citrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tamoxifen Citrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.